Assessment of Ki67 immunohistochemical expression as a prognostic marker in breast carcinoma

1. Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2018 году. М.: ФГБУ «МНИОИ им. ПА Герцена» – филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2019. 30c. [Kaprin A.D., Starinsky V.V., Petrova G.V. Status of cancer care for the population of Russia in 2018. Moscow: P. Herzen Moscow Oncology Research Institute–Branch of FSBI NMRRC of the Ministry of Health of the Russian Federation, 2019: 30 p. (in Russian)].
2. Penault-Llorca F., Radosevic-Robin N. Ki67 assessment in breast cancer: an update.Pathology. 2017; 49(2): 166–71. doi: 10.1016/j.pathol.2016.11.006
3. Jing N., Fang C., Williams D.S. Validity and reliability of Ki-67 assessment in oestrogen receptor positive breast cancer. Pathology. 2017; 49(4): 371–8. doi: 10.1016/j.pathol.2017.02.001.
4. Rakha E.A., Green A.R. Molecular classification of breast cancer: what the pathologist needs to know. Pathology. 2017; 49(2): 111–9. doi: 10.1016/j.pathol.2016.10.012.
5. Harvey J., Thomas C., Wood B., Hardie M., Dessauvagie B., Combrinck M., Frost F.A., Sterrett G. Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting. Pathology. 2015; 47(1): 13–20. doi: 10.1097/PAT.0000000000000192.
6. Кушнарев В.А., Артемьева Е.С., Кудайбергенова А.Г. Сравнение цифрового и визуального методов для оценки индекса Ki-67 в инвазивных карциномах молочной железы. Архив патологии. 2018; 80(2): 38–42.[Kushnarev V.A., Artemyeva A.C., Kudaybergenova A.G. Comparison of digital and visual methods for Ki-67 assessment in invasive breast carcinomas. Archive of Pathology = Arkhiv Patologii. 2018; 80(2): 38–42. (in Russian)]. doi:10.17116/patol201880238-42
7. Elmore J.G., Nelson H.D., Pepe M.S., Longton G.M., Tosteson A.N., Geller B., Onega T., Carney P.A., Jackson S.L., Allison K.H., Weaver D.L. Variability in pathologists’ interpretations of individual breast biopsy slides: a population perspective. Ann Intern Med. 2016; 164(10): 649–55. doi: 10.7326/M15-0964.
8. Williams B.J., Hanby A., Millican-Slater R., Nijhawan A., Verghese E., Treanor D. Digital pathology for the primary diagnosis of breast histopathological specimens: an innovative validation and concordance study on digital pathology validation and training. Histopathology. 2018; 72(4): 662–71. doi: 10.1111/his.13403.
9. Del Rosario Taco Sanchez M., Soler-Monsó T., Petit A., Azcarate J., Lasheras A., Artal C., Gil M., Falo C., Pla M.J., Matias-Guiu X. Digital quantification of KI-67 in breast cancer. Virchows Archiv. 2019; 474(2): 169–76. doi: 10.1007/s00428-018-2481-3.
10. Elmore J.G., Longton G.M., Pepe M.S., Carney P.A, Nelson H.D., Allison K.H., Geller B.M., Onega T., Tosteson A.N., Mercan E., Shapiro L.G., Brunyé T.T., Morgan T.R., Weaver D.L. A randomized study comparing digital imaging to traditional glass slide microscopy for breast biopsy and cancer diagnosis. J Pathol Inform. 2017; 8:12. doi: 10.4103/2153-3539.201920.
11. Joshi S., Watkins J., Gazinska P., et al. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value. BMC Cancer. 2015; 15: 546. doi:10.1186/s12885-015-1531-3
12. Menter D.G., Hoque A., Motiwala N., Sahin A.A., Sneige N., Lieberman R., Lippman S.M. Computerized image analysis of Ki-67 in ductal breast carcinoma in situ. Anal Quant Cytol Histol. 2001; 23(3): 218–28. PMID: 11444192
13. Прилепская Е.А., и др. Возможности автоматизированного анализа изображений в патологии. Архив патологии. 2016; 78(1): 51–5. [Prilepskaya E.A., et al. Possibilities of automated image analysis in pathology. Archive of Pathology = Arkhiv Patologii. 2016; 78 (1): 51–5. (in Russian)] 10.17116/patol201678151-55
14. Zhong F., Bi R., Yu B., Yang F., Yang W., Shui R. A comparison of visual assessment and automated digital image analysis of Ki67 labeling index in breast cancer. PloS one. 2016; 11(2): e0150505. doi: 10.1371/journal.pone.0150505
15. Varga Z., Cassoly E., Li Q., Oehlschlegel C., Tapia C., Lehr H.A., Klingbiel D., Thürlimann B., Ruhstaller T. Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study. PLoS One. 2015; 10(4): e0123435. doi: 10.1371/journal.pone.0123435
16. Plancoulaine B., Laurinaviciene A., Herlin P., Besusparis J., Meskauskas R., Baltrusaityte I., Iqbal Y., Laurinavicius A. A methodology for comprehensive breast cancer Ki67 labeling index with intra-tumor heterogeneity appraisal based on hexagonal tiling of digital image analysis data. Virchows Archiv. 2015; 467(6): 711–22. doi: 10.1007/s00428-015-1865-x
17. Rakha E.A., Aleskandarani M., Toss M.S., et al. Breast cancer histologic grading using digital microscopy: concordance and outcome association. Journal of clinical pathology. 2018; 71(8): 680–6. doi:10.1136/jclinpath-2017-204979

Received 23.12.2019

Accepted 26.12.2019